360 related articles for article (PubMed ID: 18573422)
21. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.
Yousem SA; Zeevi A
Am J Surg Pathol; 2012 Jul; 36(7):987-92. PubMed ID: 22510758
[TBL] [Abstract][Full Text] [Related]
22. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
[TBL] [Abstract][Full Text] [Related]
23. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
24. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
[TBL] [Abstract][Full Text] [Related]
25. Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.
Tiriveedhi V; Gautam B; Sarma NJ; Askar M; Budev M; Aloush A; Hachem R; Trulock E; Myers B; Patterson AG; Mohanakumar T
J Heart Lung Transplant; 2013 Aug; 32(8):807-14. PubMed ID: 23856218
[TBL] [Abstract][Full Text] [Related]
26. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
[TBL] [Abstract][Full Text] [Related]
27. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
[TBL] [Abstract][Full Text] [Related]
28. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.
Morrell MR; Pilewski JM; Gries CJ; Pipeling MR; Crespo MM; Ensor CR; Yousem SA; D'Cunha J; Shigemura N; Bermudez CA; McDyer JF; Zeevi A
J Heart Lung Transplant; 2014 Dec; 33(12):1288-94. PubMed ID: 25443870
[TBL] [Abstract][Full Text] [Related]
29. Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome.
Reznik SI; Jaramillo A; Zhang L; Patterson GA; Cooper JD; Mohanakumar T
J Thorac Cardiovasc Surg; 2000 Jan; 119(1):39-45. PubMed ID: 10612759
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of current strategies for surveillance and management of donor-specific antibodies: Single-center study.
Sullivan D; Ahn C; Gao A; Lacelle C; Torres F; Bollineni S; Banga A; Mullins J; Mohanka M; Ring S; Wait M; Peltz M; Duddupudi P; Surapaneni D; Kaza V
Clin Transplant; 2018 Jul; 32(7):e13285. PubMed ID: 29774598
[TBL] [Abstract][Full Text] [Related]
31. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.
Kauke T; Kneidinger N; Martin B; Dick A; Schneider C; Schramm R; Meimarakis G; Preissler G; Eickelberg O; von Dossow V; Behr J; Hatz R; Neurohr C; Winter H
Tissue Antigens; 2015 Sep; 86(3):178-85. PubMed ID: 26204790
[TBL] [Abstract][Full Text] [Related]
32. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
33. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
35. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
[TBL] [Abstract][Full Text] [Related]
36. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
[TBL] [Abstract][Full Text] [Related]
37. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
Stuckey LJ; Kamoun M; Chan KM
Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499
[TBL] [Abstract][Full Text] [Related]
38. Pre-transplant presence of antibodies to MICA and HLA class I or II are associated with an earlier onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Lyu DM; Grazia TJ; Benson AB; Cagle LR; Freed BM; Zamora MR
Clin Transpl; 2012; ():237-46. PubMed ID: 23721028
[TBL] [Abstract][Full Text] [Related]
39. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation.
Hoffman SA; Wang L; Shah CV; Ahya VN; Pochettino A; Olthoff K; Shaked A; Wille K; Lama VN; Milstone A; Ware LB; Orens J; Weinacker A; Demissie E; Bellamy S; Kawut SM; Hancock WW; Christie JD;
Am J Transplant; 2009 Feb; 9(2):389-96. PubMed ID: 19120076
[TBL] [Abstract][Full Text] [Related]
40. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
